Financhill
Back

Corcept Therapeutics Vs. Akebia Therapeutics Industry Stock Comparison

Buy
78

CORT
Corcept Therapeutics

Last Price:
57.51
Seasonality Move:
2.29%
Buy
63

AKBA
Akebia Therapeutics

Last Price:
1.87
Seasonality Move:
46.76%
Buy
78
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $57.54. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.88. The Score for AKBA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $57.54
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.45 Buy
Relative Strength Index (14 RSI): 64.7 Buy
Chaikin Money Flow: 529493 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.23 - 56.35) Buy
Bollinger Bands (100): (33.06 - 49.28) Buy

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 61.05 Buy
Chaikin Money Flow: 1174085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.62 - 1.92) Buy
Bollinger Bands (100): (1.22 - 1.68) Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.94 Buy
20-day SMA: 53.34 Buy
50-day SMA: 48.23 Buy
200-day SMA: 33.69 Buy
8-day EMA: 55.47 Buy
20-day EMA: 53.46 Buy
50-day EMA: 48.61 Buy
200-day EMA: 37.24 Buy

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.84 Buy
20-day SMA: 1.83 Buy
50-day SMA: 1.55 Buy
200-day SMA: 1.41 Buy
8-day EMA: 1.84 Buy
20-day EMA: 1.79 Buy
50-day EMA: 1.63 Buy
200-day EMA: 1.41 Buy

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):